Olopatadine Hcl Solution/ Drops
NDC Package 70512-520-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Olopatadine Hcl solution/ dropses is a medication an antihistamine used to treat itching and redness in the eyes due to allergies. This formulation utilizes a solution/ drops delivery system. Marketed by Sola Pharmaceuticals, this product is identified by NDC 70512-520 and is authorized under FDA application ANDA203152.

Identification & Billing

NDC Package Code
70512-520-05
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 5 mL in 1 BOTTLE, PLASTIC
Product Code
70512-520
11-Digit Billing Format
70512052005
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Olopatadine Hcl
Non-Proprietary Name
Olopatadine Hcl
Substance Name
Olopatadine Hydrochloride
Dosage Form
Solution/ Drops - A solution which is usually administered in a drop-wise fashion.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
OLOPATADINE HYDROCHLORIDE 1 mg/mL
Pharmacologic Class
Usage Information
This medication is an antihistamine used to treat itching and redness in the eyes due to allergies. This medication is not recommended for the treatment of eye irritation due to wearing contact lenses.

Regulatory & Marketing

Labeler Name
Sola Pharmaceuticals
Product Type
Human Otc Drug
FDA Application #
ANDA203152
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-05-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70512-520-05 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 5 ml in 1 bottle, plastic of Olopatadine Hcl, a human over the counter drug labeled by Sola Pharmaceuticals. This solution/ drops is formulated for ophthalmic use and contains olopatadine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sola Pharmaceuticals on July 05, 2022. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is an antihistamine used to treat itching and redness in the eyes due to allergies. This medication is not recommended for the treatment of eye irritation due to wearing contact lenses.

How is this Sola Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70512052005. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70512-520-05
11-Digit CMS (5-4-2)
70512-0520-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.